Moderna
MRNA
MRNA
879 hedge funds and large institutions have $25.5B invested in Moderna in 2023 Q3 according to their latest regulatory filings, with 81 funds opening new positions, 353 increasing their positions, 299 reducing their positions, and 143 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
879
Holders Change
-77
Holders Change %
-8.05%
% of All Funds
14.01%
Holding in Top 10
13
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-7.14%
% of All Funds
0.21%
New
81
Increased
353
Reduced
299
Closed
143
Calls
$1.7B
Puts
$1.53B
Net Calls
+$172M
Net Calls Change
+$317M
Top Buyers
| 1 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
+$175M |
| 2 |
UBS AM
Chicago,
Illinois
|
+$98.9M |
| 3 |
FGAM
Financial Gravity Asset Management
Lakeway,
Texas
|
+$90.3M |
| 4 |
Norges Bank
Oslo,
Norway
|
+$88.2M |
| 5 |
TP
Theleme Partners
London,
United Kingdom
|
+$67.3M |
Top Sellers
| 1 |
FP
Flagship Pioneering
Cambridge,
Massachusetts
|
-$333M |
| 2 |
LPC
Lone Pine Capital
Greenwich,
Connecticut
|
-$186M |
| 3 |
Coatue Management
New York
|
-$169M |
| 4 |
Two Sigma Investments
New York
|
-$78.3M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$64.1M |
